VERTEX PHARMACEUTICALS INC / MA Financing Cash Flow
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Financing Cash Flow of -$965.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$426.70M.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$538.80M.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$77.20M.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$1.15B.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) financing activities for fiscal 2025 was -$2.26B.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) financing activities for fiscal 2024 was -$1.49B.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) financing activities for fiscal 2023 was -$562.20M.
- VERTEX PHARMACEUTICALS INC / MA net cash provided by (used in) financing activities for fiscal 2022 was -$67.70M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$426.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$965.50M 10-Q · filed 2026-08-04 | -$1.04B derived: sum of 3 quarters · filed 2026-08-04 | -$2.20B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$538.80M 10-Q · filed 2026-05-05 | -$616.00M derived: sum of 2 quarters · filed 2026-05-05 | -$1.77B derived: sum of 3 quarters · filed 2026-05-05 | -$2.12B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$77.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$1.23B derived: sum of 2 quarters · filed 2026-02-13 | -$1.58B derived: sum of 3 quarters · filed 2026-08-04 | -$2.26B 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | -$1.15B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.50B derived: sum of 2 quarters · filed 2026-08-04 | -$2.18B 10-Q · filed 2025-11-04 | -$2.58B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$349.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.03B 10-Q · filed 2026-08-04 | -$1.42B derived: sum of 3 quarters · filed 2026-08-04 | -$1.81B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$680.40M 10-Q · filed 2026-05-05 | -$1.07B derived: sum of 2 quarters · filed 2026-05-05 | -$1.46B derived: sum of 3 quarters · filed 2026-05-05 | -$1.82B derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$391.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$778.80M derived: sum of 2 quarters · filed 2026-02-13 | -$1.14B derived: sum of 3 quarters · filed 2026-02-13 | -$1.49B 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | -$387.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$746.10M derived: sum of 2 quarters · filed 2025-11-04 | -$1.10B 10-Q · filed 2025-11-04 | -$1.22B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | -$358.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$716.10M 10-Q · filed 2025-08-05 | -$835.90M derived: sum of 3 quarters · filed 2026-02-13 | -$1.00B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | -$357.50M 10-Q · filed 2025-05-06 | -$477.30M derived: sum of 2 quarters · filed 2026-02-13 | -$642.30M derived: sum of 3 quarters · filed 2026-02-13 | -$625.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | -$119.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$284.80M derived: sum of 2 quarters · filed 2026-02-13 | -$267.50M derived: sum of 3 quarters · filed 2026-02-13 | -$562.20M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | -$165.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$147.70M derived: sum of 2 quarters · filed 2024-11-05 | -$442.40M 10-Q · filed 2024-11-05 | -$402.20M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $17.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$277.40M 10-Q · filed 2024-08-02 | -$237.20M derived: sum of 3 quarters · filed 2025-02-13 | -$297.40M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | -$294.70M 10-Q · filed 2024-05-07 | -$254.50M derived: sum of 2 quarters · filed 2025-02-13 | -$314.70M derived: sum of 3 quarters · filed 2025-02-13 | -$267.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $40.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$20.00M derived: sum of 2 quarters · filed 2025-02-13 | $27.70M derived: sum of 3 quarters · filed 2025-02-13 | -$67.70M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | -$60.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$12.50M derived: sum of 2 quarters · filed 2023-11-07 | -$107.90M 10-Q · filed 2023-11-07 | -$444.10M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $47.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$47.70M 10-Q · filed 2023-08-02 | -$383.90M derived: sum of 3 quarters · filed 2024-02-15 | -$1.04B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$95.40M 10-Q · filed 2023-05-02 | -$431.60M derived: sum of 2 quarters · filed 2024-02-15 | -$1.09B derived: sum of 3 quarters · filed 2024-02-15 | -$1.05B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | -$336.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$992.90M derived: sum of 2 quarters · filed 2024-02-15 | -$959.30M derived: sum of 3 quarters · filed 2024-02-15 | -$1.48B 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | -$656.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$623.10M derived: sum of 2 quarters · filed 2022-10-28 | -$1.14B 10-Q · filed 2022-10-28 | -$1.14B 10-Q · filed 2021-11-03 | -$1.27B derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | $33.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$485.10M 10-Q · filed 2022-08-05 | -$485.10M 10-Q · filed 2021-07-30 | -$610.31M derived: sum of 3 quarters · filed 2023-02-10 | -$751.00M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | -$518.70M 10-Q · filed 2022-05-06 | -$518.65M 10-Q · filed 2021-04-30 | -$643.91M derived: sum of 2 quarters · filed 2023-02-10 | -$784.60M derived: sum of 3 quarters · filed 2023-02-10 | -$664.57M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | -$125.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$265.89M derived: sum of 2 quarters · filed 2023-02-10 | -$145.87M derived: sum of 3 quarters · filed 2023-02-10 | -$505.30M 10-K · filed 2023-02-10 | -$505.28M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | -$140.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$20.66M derived: sum of 2 quarters · filed 2021-11-03 | -$380.09M 10-Q · filed 2021-11-03 | -$218.64M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $120.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$239.41M 10-Q · filed 2021-07-30 | -$77.96M derived: sum of 3 quarters · filed 2022-02-09 | -$57.60M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | -$359.43M 10-Q · filed 2021-04-30 | -$197.98M derived: sum of 2 quarters · filed 2022-02-09 | -$177.63M derived: sum of 3 quarters · filed 2022-02-09 | -$190.64M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $161.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $181.80M derived: sum of 2 quarters · filed 2022-02-09 | $168.79M derived: sum of 3 quarters · filed 2022-02-09 | $126.80M 10-K · filed 2022-02-09 | $126.77M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $20.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $7.34M derived: sum of 2 quarters · filed 2020-10-30 | -$34.65M 10-Q · filed 2020-10-30 | -$135.69M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | -$13.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$55.00M 10-Q · filed 2020-07-31 | -$156.05M derived: sum of 3 quarters · filed 2021-02-11 | -$153.97M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | -$41.99M 10-Q · filed 2020-05-01 | -$143.03M derived: sum of 2 quarters · filed 2021-02-11 | -$140.96M derived: sum of 3 quarters · filed 2021-02-11 | -$192.16M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | -$101.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$98.97M derived: sum of 2 quarters · filed 2021-02-11 | -$150.18M derived: sum of 3 quarters · filed 2021-02-11 | -$71.22M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$49.13M derived: sum of 2 quarters · filed 2019-10-31 | $29.83M 10-Q · filed 2019-10-31 | $103.06M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | -$51.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $27.75M 10-Q · filed 2019-08-01 | $100.98M derived: sum of 3 quarters · filed 2020-02-13 | $253.68M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $78.96M 10-Q · filed 2019-05-01 | $152.19M derived: sum of 2 quarters · filed 2020-02-13 | $304.89M derived: sum of 3 quarters · filed 2020-02-13 | $436.93M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $73.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $225.94M derived: sum of 2 quarters · filed 2020-02-13 | $357.97M derived: sum of 3 quarters · filed 2020-02-13 | $68.40M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $152.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $284.74M derived: sum of 2 quarters · filed 2018-10-25 | -$4.83M 10-Q · filed 2018-10-25 | $88.94M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $132.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$157.53M 10-Q · filed 2018-07-26 | -$63.77M derived: sum of 3 quarters · filed 2019-02-13 | -$50.22M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | -$289.56M 10-Q · filed 2018-04-27 | -$195.80M derived: sum of 2 quarters · filed 2019-02-13 | -$182.25M derived: sum of 3 quarters · filed 2019-02-13 | -$161.00M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $93.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $107.32M derived: sum of 2 quarters · filed 2019-02-13 | $128.57M derived: sum of 3 quarters · filed 2019-02-13 | $133.27M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $13.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $34.81M derived: sum of 2 quarters · filed 2017-10-30 | $39.51M 10-Q · filed 2017-10-30 | $92.15M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $21.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $25.95M 10-Q · filed 2017-07-28 | $78.59M derived: sum of 3 quarters · filed 2018-02-15 | $128.26M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $4.70M 10-Q · filed 2017-04-28 | $57.34M derived: sum of 2 quarters · filed 2018-02-15 | $107.01M derived: sum of 3 quarters · filed 2018-02-15 | $143.21M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $52.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $102.31M derived: sum of 2 quarters · filed 2018-02-15 | $138.50M derived: sum of 3 quarters · filed 2018-02-15 | $188.92M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $49.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $85.86M derived: sum of 2 quarters · filed 2016-10-31 | $136.28M 10-Q · filed 2016-10-31 | $91.12M 10-Q · filed 2015-10-30 | ||||
| 2015-06-30 | $36.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $86.61M 10-Q · filed 2016-08-01 | ||||||
| 2015-03-31 | $50.41M 10-Q · filed 2016-05-03 | |||||||
| 2014-09-30 | $441.05M 10-Q · filed 2015-10-30 | |||||||
| 2011-06-30 | $55.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $38.67M 10-Q · filed 2011-08-09 | $48.12M derived: sum of 3 quarters · filed 2011-08-09 | $446.62M derived: sum of 4 quarters · filed 2011-08-09 | ||||
| 2011-03-31 | -$16.36M 10-Q · filed 2011-05-06 | -$6.91M derived: sum of 2 quarters · filed 2011-05-06 | $391.58M derived: sum of 3 quarters · filed 2011-05-06 | $401.06M derived: sum of 4 quarters · filed 2011-08-09 | ||||
| 2010-12-31 | $9.45M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $407.94M derived: sum of 2 quarters · filed 2011-02-17 | $417.42M derived: sum of 3 quarters · filed 2011-08-09 | $425.06M 10-K · filed 2011-02-17 | ||||
| 2010-09-30 | $398.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $407.97M derived: sum of 2 quarters · filed 2011-08-09 | $415.61M 10-Q · filed 2010-10-28 | $954.27M derived: sum of 4 quarters · filed 2011-08-09 | ||||
| 2010-06-30 | $9.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $17.11M 10-Q · filed 2011-08-09 | $555.78M derived: sum of 3 quarters · filed 2011-08-09 | $686.37M derived: sum of 4 quarters · filed 2011-08-09 | ||||
| 2010-03-31 | $7.64M 10-Q · filed 2011-05-06 | $546.31M derived: sum of 2 quarters · filed 2011-05-06 | $676.90M derived: sum of 3 quarters · filed 2011-05-06 | $687.98M derived: sum of 4 quarters · filed 2011-05-06 | ||||
| 2009-12-31 | $538.66M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $669.26M derived: sum of 2 quarters · filed 2011-02-17 | $680.34M derived: sum of 3 quarters · filed 2011-02-17 | $999.01M 10-K · filed 2011-02-17 | ||||
| 2009-09-30 | $130.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $141.67M derived: sum of 2 quarters · filed 2010-10-28 | $460.34M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $11.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | $329.75M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | $318.67M 10-Q · filed 2010-05-03 | |||||||
| 2008-12-31 | $620.74M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |